Kopran informs about presentation

11 Jun 2021 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, Kopran has informed that it has enclosed presentation on Q4FY21 earning of the Company. A copy of the said presentation is also being uploaded on the Company's website www.kopran.com.

The above information is a part of company’s filings submitted to BSE.

Kopran Share Price

135.60 -4.10 (-2.93%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×